537 related articles for article (PubMed ID: 35396575)
1. γ-Secretase in Alzheimer's disease.
Hur JY
Exp Mol Med; 2022 Apr; 54(4):433-446. PubMed ID: 35396575
[TBL] [Abstract][Full Text] [Related]
2. Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides.
Liu L; Lauro BM; Wolfe MS; Selkoe DJ
J Biol Chem; 2021; 296():100393. PubMed ID: 33571524
[TBL] [Abstract][Full Text] [Related]
3. Development and mechanism of γ-secretase modulators for Alzheimer's disease.
Crump CJ; Johnson DS; Li YM
Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767
[TBL] [Abstract][Full Text] [Related]
4. γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not.
Lessard CB; Rodriguez E; Ladd TB; Minter LM; Osborne BA; Miele L; Golde TE; Ran Y
Alzheimers Res Ther; 2020 May; 12(1):61. PubMed ID: 32430033
[TBL] [Abstract][Full Text] [Related]
5. γ-Secretase inhibitors and modulators.
Golde TE; Koo EH; Felsenstein KM; Osborne BA; Miele L
Biochim Biophys Acta; 2013 Dec; 1828(12):2898-907. PubMed ID: 23791707
[TBL] [Abstract][Full Text] [Related]
6. γ-Secretase modulators show selectivity for γ-secretase-mediated amyloid precursor protein intramembrane processing.
Weber TA; Lundkvist J; Wanngren J; Kvartsberg H; Jin S; Larssen P; Wu D; Oliveira DV; Minta K; Brinkmalm G; Zetterberg H; Blennow K; Nordvall G; Winblad B; Portelius E; Karlström H
J Cell Mol Med; 2022 Feb; 26(3):880-892. PubMed ID: 34931449
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
Evin G; Sernee MF; Masters CL
CNS Drugs; 2006; 20(5):351-72. PubMed ID: 16696577
[TBL] [Abstract][Full Text] [Related]
8. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
[TBL] [Abstract][Full Text] [Related]
9. Intramembrane proteolysis by gamma-secretase.
Steiner H; Fluhrer R; Haass C
J Biol Chem; 2008 Oct; 283(44):29627-31. PubMed ID: 18650432
[TBL] [Abstract][Full Text] [Related]
10. Gamma Secretase as an Important Drug Target for Management of Alzheimer's Disease: A Comprehensive Review.
Hakem FT; Fouad YF; Arafa RK
Curr Top Med Chem; 2024; 24(2):109-127. PubMed ID: 37818580
[TBL] [Abstract][Full Text] [Related]
11. Inhibition and modulation of gamma-secretase for Alzheimer's disease.
Wolfe MS
Neurotherapeutics; 2008 Jul; 5(3):391-8. PubMed ID: 18625450
[TBL] [Abstract][Full Text] [Related]
12. Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes.
Lee J; Song L; Terracina G; Bara T; Josien H; Asberom T; Sasikumar TK; Burnett DA; Clader J; Parker EM; Zhang L
Biochemistry; 2011 Jun; 50(22):4973-80. PubMed ID: 21528914
[TBL] [Abstract][Full Text] [Related]
13. Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid β peptide length: support for a sequential model of γ-secretase intramembrane proteolysis and regulation by the amyloid β precursor protein (APP) juxtamembrane region.
Kukar TL; Ladd TB; Robertson P; Pintchovski SA; Moore B; Bann MA; Ren Z; Jansen-West K; Malphrus K; Eggert S; Maruyama H; Cottrell BA; Das P; Basi GS; Koo EH; Golde TE
J Biol Chem; 2011 Nov; 286(46):39804-12. PubMed ID: 21868378
[TBL] [Abstract][Full Text] [Related]
14. Extracellular interface between APP and Nicastrin regulates Aβ length and response to γ-secretase modulators.
Petit D; Hitzenberger M; Lismont S; Zoltowska KM; Ryan NS; Mercken M; Bischoff F; Zacharias M; Chávez-Gutiérrez L
EMBO J; 2019 Jun; 38(12):. PubMed ID: 31109937
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of γ-secretase stabilize the complex and differentially affect processing of amyloid precursor protein and other substrates.
Barthet G; Shioi J; Shao Z; Ren Y; Georgakopoulos A; Robakis NK
FASEB J; 2011 Sep; 25(9):2937-46. PubMed ID: 21597003
[TBL] [Abstract][Full Text] [Related]
16. γ-Secretase and its modulators: Twenty years and beyond.
Xia W
Neurosci Lett; 2019 May; 701():162-169. PubMed ID: 30763650
[TBL] [Abstract][Full Text] [Related]
17. The Large Ectodomain of APP Prevents APP from being Directly Cleaved by γ-Secretase.
Li Y; Li H; Liang W; Li Y; Wang Z
Front Biosci (Landmark Ed); 2024 Feb; 29(2):78. PubMed ID: 38420818
[TBL] [Abstract][Full Text] [Related]
18. The Alzheimer's disease-associated gamma-secretase complex: functional domains in the presenilin 1 protein.
Laudon H; Winblad B; Näslund J
Physiol Behav; 2007 Sep; 92(1-2):115-20. PubMed ID: 17588625
[TBL] [Abstract][Full Text] [Related]
19. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
